EUROAPI’s General Meeting Scheduled: Key Details for Shareholders

Author: Thomas Cooper Updated: 04-29-2025 11:47 AM

Upcoming Combined General Meeting Details

EUROAPI invites its valued shareholders to participate in the Combined General Meeting slated for May 21, 2025, at 10:30 a.m. (CET). This significant gathering will take place at the company's office on rue Traversière in Paris.

Meeting Notification and Document Availability

An official notice regarding the meeting was disclosed in the French Journal of Legal Announcements on April 16, 2025. Shareholders can access all necessary documents and information mandated by the French Commercial Code directly on the EUROAPI website, specifically in the “Annual General Meeting 2025” section.

How to Access Additional Documents

Registered shareholders wishing to obtain further documents can do so within the established deadlines by reaching out via email or requesting them at the company’s registered address. Those shareholders who hold their shares in registered form will receive all necessary convening information either by post or electronically, depending on their preferences.

Support for Bearer Shareholders

For those holding bearer shares, it’s recommended to contact their financial intermediaries for specific instructions regarding the meeting documentation. Staying informed is crucial, and all shareholders are encouraged to check the dedicated meeting section on the company's website for the latest updates.

Annual General Meeting Broadcast and Replay Information

The forthcoming General Meeting will be available for live viewing, barring any potential technical difficulties. Furthermore, there will be a playback option for those who want to revisit the event later. Access to this replay will also be provided through the relevant section of EUROAPI's website.

About EUROAPI

EUROAPI is a frontrunner in the field of active pharmaceutical ingredients, dedicated to innovating sustainable solutions that cater to both customers and patients globally. With an impressive portfolio of approximately 200 products, the company is at the forefront of developing groundbreaking molecules through its CDMO endeavors.

Our 3,430-strong team is fueled by a commitment to enhancing health outcomes by ensuring accessibility to essential therapies. With robust R&D capabilities and six strategically located manufacturing sites across Europe, EUROAPI guarantees the highest quality in API production, serving clientele in over 80 countries. Notably, EUROAPI is listed on Euronext Paris with the ticker symbol EAPI.

Contact Information for Shareholders

For any media inquiries or investor relations, shareholders can reach out to the following:

Media Relations Contact

Laurence Bollack
Telephone: +33 (0)6 81 86 80 19
Email: mr@euroapi.com

Investor Relations Contact

Sophie Palliez-Capian
Telephone: +33 (0)6 87 89 33 51
Email: Sophie.palliez@euroapi.com

Frequently Asked Questions

What is the date and time of the Combined General Meeting?

The meeting is scheduled for May 21, 2025, at 10:30 a.m. (CET).

Where can shareholders find the preparatory documents?

Documents are accessible on EUROAPI's website under the “Annual General Meeting 2025” section.

How can registered shareholders obtain additional documents?

Registered shareholders can request documents via email or by contacting the company’s registered office.

Will the meeting be available for live viewing?

Yes, the General Meeting will be broadcast live and can also be replayed later on the company’s website.

Where can I learn more about EUROAPI?

For more information on EUROAPI, visit their official website or follow them on LinkedIn.

About The Author

Hello, I'm Thomas Cooper, a financial expert and writer passionate about helping people understand and navigate the financial world. Having a solid financial background and a lot of experience, my area of expertise is simplifying difficult financial ideas into useful, understandable guidance. My goal with my writings and blog entries is to provide you the information and resources you need to make wise financial choices.

I am thrilled to contribute my ideas and engage with a lively investor community at Investors Hangout, where I recently joined the team. My mission is to make finance interesting and approachable so you may take charge of your financial future. I appreciate you coming along on this path to success and financial knowledge.

Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.